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Case presentations
Patient 1. A 45-year-old man described a history of recurrent urinary
tract infections during the 6 years preceding his first visit to the New
England Medical Center Hospital (NEMCH). The initial infection was
characterized by acute chills and fever, low-back pain, urinary frequen-
cy, urgency, nocturia, dysuria, and a decrease in the force and caliber
of the urinary stream. An intravenous urogram was normal and his
infection responded to therapy with an antibiotic. During the ensuing 5
years he experienced similar episodes of recurrent symptomatic infec-
tion about once yearly. Each time, the symptoms abated following short
courses of antibiotic therapy. During the 5 months that immediately
preceded his referral, he experienced three separate episodes of symp-
tomatic urinary tract infection.
When examined initially, he was asymptomatic while taking ampicil-
lin orally. Physical examination disclosed normal external genitalia and
modest symmetrical enlargement of the prostate without nodules.
Laboratory findings included a hematocrit of 40% and a serum creati-
nine of 1.0 mg/dl. The urine spun sediment was normal, but bacteriolog-
ic localization cultures were positive for prostatic infection due to Esch-
erichia coli (serogroup 04), and were sensitive to several antimicrobial
agents, including ampicillin and trimethoprim-sulfamethoxazole (Table
I). The titer of serum antibody against this 04 E, coli was elevated
(1:1280). An intravenous urogram was normal.
After additional cultures confirmed a diagnosis of prostatitis due to 04
E. coli, therapy was initiated with two tablets orally of trimethoprim-
sulfamethoxazole (TMP-SMX), twice daily. During a 12-week course of
treatment, the patient remained asymptomatic and all cultures remained
sterile (Table 1). Throughout a 7-month follow-up, he remained asymp-
tomatic and had sterile cultures while he was taking no medication. The
titer of serum antibody against the 04 E. coli also fell to normal (1:160).
Patient 2. A 66-year-old man first experienced a febrile urinary tract
infection due to E. coli several days after an indwelling urethral catheter
inserted during elective abdominal surgery was removed. He initially
responded to therapy with ampicillin but relapsed with a recurrent
febrile urinary tract infection due to E. co/i a few days after completion
of antibiotic therapy.
He was examined initially at the NEMCH and on the sixth day of
repeat therapy with ampicillin was asymptomatic. Physical findings
disclosed normal external genitalia and moderate symmetrical enlarge-
ment of the prostate without nodules. Laboratory findings included a
hematocrit of 42.5% and a serum creatinine of 1.1 mg/dl. The urine spun
sediment was normal and bacteriologic localization cultures proved
prostatitis due to E. coli (serogroup 04) that was sensitive to several
antimicrobial agents, including ampicillin and TMP-SMX (Table 2). The
titer of serum antibody against this 04 E. co/i was elevated (1:2560). An
intravenous urogram was normal and specifically excluded prostatic
calcifications and significant postvoid residual.
Therapy was initiated with TMP-SMX, two tablets orally, twice
daily. Throughout a 12-week course of therapy, the patient remained
essentially asymptomatic; however, prostatic cultures remained posi-
tive for 04 E. co/i, and the serum antibody titer against the 04 E. coli
remained elevated (1:2560) (Table 2).
Patient 3. A 50-year-old man was evaluated at the NEMCH because
of urinary frequency, urgency, and dysuria. About 10 years previously
he had undergone surgical removal of a large bladder calculus in Brazil.
He was unaware of any subsequent genitourinary tract difficulties.
Physical examination disclosed a small but firm and moderately tender
prostate. Laboratory findings revealed the following: hematocrit, 47%;
BUN, 16 mg/dl; and serum creatinine, 1.0 mg/dl. The urine spun
sediment showed pyuria (50 to 60 white blood cells per high-power
field), and a culture of midstream urine grew more than 100,000
Kiebsie/la pneumoniae per ml; the organism was sensitive to sulfon-
amides, cephalosporin, nitrofurantoin, tetracycline, gentamicin, kana-
mycin, and chloramphenicol. An intravenous urogram was normal,
except for multiple prostatic calculi and minimal postvoid residual.
Throughout the ensuing 4 years, the patient experienced relapsing
bacteriuria due to K. pneumoniae despite prolonged therapy with
various appropriate antimicrobial agents (Table 3). Two years ago,
bacteriologic localization cultures confirmed a diagnosis of chronic
calculous prostatitis due to K. pneumoniae (Table 3). He eventually
developed exfoliative skin eruptions during therapy with nitrofurantoin,
cephalexin, and possibly TMP-SMX.
Six months ago, while the patient was receiving intravenous gentami-
cm therapy, an uncomplicated transurethral resection of the prostate
was performed. Resection included all intracapsular tissue and multiple
prostatic calculi, several of which were recovered for stone culture.
Cultures confirmed infection of the inner portions of the calculi with K.
pneumoniae (Table 3). Postoperative x-ray films of the pelvis disclosed
no residual calculi. The patient was discharged from the hospital on the
fourth postoperative day on therapy with TMP-SMX. This medication
was discontinued 2 weeks later because of skin eruptions. Subsequent
follow-up confirmed apparent cure of the chronic genitourinary tract
infection.
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Table 1. Chronic prostatitis cured by medical therapy
Colonies per mla
Days on (+) or
off(—) drug VBU' VB2 EPSd
Antibody
titersVB3'
+2 Ampicillin 140 30 3000 410
+9 Ampicillin 0 0 100 0
—5 Ampicillin 2500 3000 5000 1500
—12 Ampicillin 20 10 100 20 1:1280
+ 14 TMP-SMX 0 0 0 0
+36 TMP-SMX 0 0 0 0 1:1280
+57 TMP-SMX 0 0 0 0 1:1280
+93 TMP-SMX 0 0 0 0 1:640
—41 TMP-SMX 0 0 0 0 1:640
—76 TMP-SMX 0 0 0 0 1:320
—95 TMP-SMX 0 0 0 0 1:320
—123 TMP-SMX 0 0 0 0
—196 TMP-SMX 0 0 0 0 1:160
a All organisms cultured were E. coli.
b VBI refers to the first voided 10 ml of urine (urethral culture).
VB2 refers to midstream aliquot (bladder culture).
d EPS refers to expressed prostatic secretions (prostatic culture).
a VB3 refers to the first voided 10 ml of urine after prostatic massage (prostatic culture).
TMP-SMX refers to trimethoprim-sulfamethoxazole.
Table 2. Chronic prostatitis not cured by medical therapy
Colonies per mla
Days on (+) or
off(—) Drug VB1 VB2 EPS
.
Antibody
titerVB3
No medication — 100,000 — —
—8 Ampicillin — 100,000 —
+2 Ampicillin — 0 —
+4 Ampicillin — 0 — —
+5 Ampicillin — 0 — —
+6 Ampicillin 40 0 100,000 1,000 1:2560
+10 Ampicillin 0 0 10,000 70
+28 TMPSMX 20 0 6,000 10 1:2560
+56 TMP-SMX 530 200 40,000 2,000 1:2560
+84 TMP-SMX 1000 200 30,000 1,000 1:2560
a All organisms cultured were E. coli.
Discussion
DR. EDWIN M. MEARES, JR. (Charles M. Whitney Professor
and Chairman, Division of Urology, Tufts University School of
Medicine; Chairman, Department of Urology, New England
Medical Center Hospital, Boston, Massachusetts): These 3
patients illustrate some of the features of chronic bacterial
prostatitis as well as the efficacy of various therapies. Patient 1
demonstrates cure by medical therapy of chronic prostatitis
caused by 04 E. coli; Patient 2 is an example of a failure of
medical therapy to cure chronic prostatitis caused by 04 E. coli;
Patient 3 illustrates failure of medical therapy but cure by
surgical treatment of chronic calculous prostatitis caused by
Klebsiella pneumoniae.
Chronic prostatitis is a common but confusing syndrome.
Most of the confusion stems from the common misconception
that prostatitis is a single disease. To the contrary, a variety of
inflammatory diseases of the prostate are recognized today
(Table 4).
Nonbacterial prostatitis
Nonbacterial prostatitis, a condition of uncertain cause, is the
most common variety of prostatic inflammation. Although the
symptoms of chronic bacterial prostatitis and nonbacterial
prostatitis often are indistinguishable, and the prostatic expres-
sate in both conditions contains abnormal numbers of inflam-
matory cells, by definition no pathogens can be identified in
patients who have nonbacterial prostatitis. A search for patho-
gens in cases of apparent nonbacterial prostatitis seemingly has
ruled out infection caused by aerobic and anaerobic bacteria,
fungi, parasites, viruses, and mycoplasmas or ureaplasmas [1—
8]. Although speculation abounds that nonbacterial prostatitis
actually represents infection caused by Chlamydia trachomatis,
there are no proven cases of prostatitis caused by this class of
organism. Indeed, a recent study using cultures and serologic
tests in 53 men having nonacute, nonbacterial prostatitis failed
to disclose a causative role for C. trachomatis [9].
Some patients who complain of symptoms of prostatitis,
especially "prostatic pain," have no apparent prostatic inflam-
mation, and their prostatic expressates are normal by microsco-
py and culture; these men suffer from prostatodynia [10]. This
syndrome probably also results from a number of different
causes. In some patients with prostatodynia, urodynamic test-
ing reveals voiding abnormalities suggestive of bladder-sphinc-
ter dyssynergia; these patients often respond to therapy with
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Table 3. Chronic caiculous prostatitis in a 50-year-old man
Days on (+) or off (—) drug
Colonies per mi
VB1 VB2 EPS VB3
First visit — 100,000 — —
—4 Suilisoxazole — 100,000 — —
+21 Nitrofurantoin — 0 —
—74 Nitrofurantoin — 100,000 — —
+42 TMP-SMX 0
—112 TMP-SMX — ioo,ooo .
—10 Sulfisoxazole — 100,000 — —
—30 Sulfisoxazole — 100,000 — —
—20 Sulfisoxazole — 100,000 — .
—14 Sulfisoxazole — 100,000 —
+63 TMP-SMX — 0
+163TMP-SMX 0 —
—353 TMP-SMX — 100,000 — —
—60 Sulfisoxazole — 100,000 —
—30 TMP-SMX — 100,000 — —
—184 TMP-SMX — 100,000
+33 Cephalexin — 0 — —
+60 Cephalexin — 0 — —
—14 Cephalexin — 100,000 — —
+33 Cephalexin 50 0 100,000 5,000
+74 Cephalexin 10 0 50,000 1,000
—10 Cephalexin — 100,000 — —
—7 Cephalexin — 100,000 — —
—83 Cephalexin — 100,000 — —
—162 Cephalexin — 100,000 — —
+1 Gentamicin
Day of surgery (CB =
Prostatic calculi:e
Wash I = 400/mi
Wash 4 = 300/mi
Ground calculi = 100,000/mi
+ 2 Gentamicin — 0 — —
—1 Gentamicin — 0 — —
+I4TMP-SMX — 0 — —
—94 TMP-SMX 0 0 — 0
—171 TMP-SMX 0 0 — 0
All organisms cultured were K. pneumoniae.
b CB refers to catheterized bladder.
Stones were washed and cultured to determine whether the stones were infected (see Ref. 16).
alpha blockers such as phenoxybenzamine; other patients expe-
rience tension myalgia of the pelvic floor [11,, 12] and respond
best to treatment with diathermy, muscle relaxants, and physio-
therapy; in still others, emotional problems appear to be
primary and psychiatric consultation is warranted.
Given that the underlying cause of nonbacterial prostatitis is
not known, it is not surprising that its cure is difficult. In such
cases therapy is best directed toward symptomatic relief. The
liberal use of hot sitz baths is uniformly helpful. During
symptomatic flareups, other useful therapies include the short-
term use of anticholinergic, analgesic, and antiinflammatory
agents. Although some clinicians advocate the use of "thera-
peutic" prostatic massage, the benefits of such therapy are
questioned by many. If one suspects infection due to urea-
plasma or chlamydia, a therapeutic trial using a tetracycline
preparation or erythromycin in maximal dosage is reasonable.
Our preference is minocycline, 100 mg orally twice daily for 14
days, or erythromycin, 500 mg orally four times daily for 14
days. Unless the response is favorable, however, further use of
antibiotics seldom is warranted. Subtotal prostatectomy is not
generally indicated in the treatment of nonbacterial prostatitis
because symptoms are often worse after surgery.
Bacterial prostatitis
Etiology and pat hogenesis. The causative agents in bacterial
prostatitis are similar in type and prevalence to those responsi-
ble for urinary tract infection. Infections caused by common
strains of Escherichia coli predominate, although infections
caused by species of proteus, klebsiella, enterobacter, pseudo-
monas, serratia, and other less common types of Gram-negative
organisms are sometimes found [13, 14]. Mixed infections,
caused by two or more strains or classes of bacteria, are not
rare. Although the role of Gram-positive bacteria as causative
agents in prostatitis is controversial, most studies indicate that
only enterococcus (Streptococcus fecalis) plays an important
causative role [15].
The pathogenesis of bacterial prostatitis is often unclear.
Possible routes of infection include (1) ascending urethral
infection; (2) reflux of infected urine into prostatic ducts that
empty into the posterior urethra; (3) invasion by rectal bacteria
via direct extension or lymphogenous spread; and (4) hematoge-
nous infection.
Gonococcal and nongonococcal urethritis develop in males
by ascending infection after vaginal inoculation of the urinary
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Uncommon forms
Gonococcal
Tuberculous
Parasitic
Mycotic
Nonspecific granulomatous
Noneosinophilic variety
Eosinophilic variety
Suspected but unproved forms
Ureaplasma or mycoplasma
Chlamydiae
Viral
meatus during sexual intercourse. Gonococcal prostatitis oc-
curs only in men who have histories of gonococcal urethritis. A
similar pathogenesis may explain some other forms of prostati-
tis. The male sexual partners of women who have pathogenic
coliforms in their vaginal cultures often show the same bacteria
in their urethral cultures (16]. These men usually are asympto-
matic, and their urethral cultures often revert to normal sponta-
neously. Stamey and Blacklock have noted the concomitant
occurrence of identical strains of coliforms in prostatic fluid
cultures in men with chronic bacterial prostatitis and in vaginal
cultures from their female sexual partners [16, 171. Substanti-
ating data are needed to confirm the relative frequency of this
mode of infection in the pathogenesis of bacterial prostatitis.
Reflux of infected urine into the prostatic ducts that empty
through the posterior urethra might be an important route of
infection. This possibility is supported by the recent observa-
tion that many prostatic calculi contain material commonly
found in urine but foreign to prostatic secretions [181. This
finding indicates that urine enters the prostatic ducts, presum-
ably by reflux, and initiates or participates in stone formation. If
urethroprostatic reflux occurs commonly, this mechanism
might prove a frequent pathway by which urinary tract bacteria
reach and infect the prostate.
Methods of diagnosis. Much of the confusion about prostati-
tis relates to imprecise diagnostic methods. History, physical
findings, and excretory urography, cystourethroscopy, and
routine urinalysis often are not diagnostic. Microscopic exami-
nation of the prostatic expressate, although an important diag-
nostic aid, can be misleading. Inflammatory cells originating
from the urethral surface, not the prostate, can contaminate the
prostatic expressate as it passes through the urethra to the
meatus during massage. To localize the site of inflammation,
the clinician always should compare the microscopic appear-
ance of the prostatic expressate with smears of the spun
sediment of the first voided 10 ml of urine (urethral specimen)
and the midstream urine (bladder specimen).
Although opinions differ regarding the number of leukocytes
in expressed prostatic secretions that comprise an abnormal
specimen, most recent studies indicate that prostatic secretions
normally contain fewer than 10 white blood cells per high-
power field [15, 19]. Expressates most indicative of prostatic
inflammation manifest leukocytosis (more than 10 white blood
cells per high-power field) and contain abnormal numbers of
lipid-laden macrophages [15]. Moreover, the finding of macro-
phages in the expressate identifies the site of inflammation as
the prostate, as macrophages are not found in urethral exu-
dates.
Isolated culture of the prostatic expressate can be misleading
for the same reason: urethral organisms of nonprostatic origin
may contaminate the prostatic fluid as it passes through the
urethra, Isolated analysis or culture of the ejaculate also can be
misleading: not only is urethral contamination possible, but the
semen is composed of fluids from various organs and sites.
Cytologic examination of the ejaculate is complicated by the
close resemblance of immature sperm cells and leukocytes.
Quantitative culture of the semen may be useful in diagnosing
bacterial prostatitis when prostatic fluid is difficult to obtain by
massage. Proper interpretation of results, however, requires
preliminary collection of urethral and bladder specimens for
comparative quantitative cultures.
Immune response. Serologic studies have demonstrated an
immune response in patients with bacterial prostatitis. When
studied by a method of 0-specific direct bacterial agglutination,
82% of men with chronic prostatitis due to various strains of E.
coli had elevated serum antibody titers against their prostatic
pathogens, whereas men with urethritis due to E. co/i and
normal men had uniformly low serum antibody titers against
urethral and fecal E. coli, respectively (Fig. 1) [20]. Further-
more, a return to normal of previously elevated serum antibody
titers has been observed in men cured of chronic prostatitis due
to E. coli, whereas serum titers remained elevated in men in
whom treatment failed [211. Jones [22] and Thomas, Shelokov,
and Forland [231 found that chronic bacterial prostatitis usually
produces a positive immunofluorescent test for antibody coat-
ing of bacteria in the urine. Gray, Billings, and Blacklock used
techniques of immunodiffusion and immunoelectrophoresis to
demonstrate significant elevations of IgG, IgA, and 1gM in the
prostatic fluid of men with chronic prostatitis [24]. It is likely
that additional investigation of the immune response in prostati-
tis will lead to improved methods of diagnosis and better
markers of disease activity.
Quantitative bacteriologic localization cultures. The per-
formance of simultaneous quantitative cultures of the urethra,
bladder urine, and expressed prostatic secretions is the most
useful method of establishing the diagnosis of bacterial prostati-
tis. We have reported previously on the details concerning
specimen collection, culture methodology, and interpretation of
results and will simply summarize them here [13, 14, 25]. The
voided urine and expressed prostatic secretions are collected as
segmented specimens: the first voided 10 ml (VB1, voided
bladder 1), the midstream aliquot (VB2), the prostatic expres-
sate obtained by prostatic massage (EPS, expressed prostatic
secretions), and the first voided 10 nil immediately after prostat-
ic massage (VB3). All specimens are cultured quantitatively by
surface streaking 0.1 ml onto blood and MacConkey agar
plates. In our view, the diagnosis of prostatic infection is
confirmed when the bacterial colony counts of the prostatic
specimens (EPS and VB3) exceed those of the urethral (VB1)
Table 4. Types of prostatitis
Common forms
Nonbacterial
Acute bacterial
Chronic bacterial
Chronic calculous
Prostatitis 293
10
9
8
05
C
2
0
<1:20 1:20 1:40 1:80 1:1601:3201:6401:12801:2560
Fig. 1. Serum antibody titers of E. coli in normal men and men with
urethritis or prostatis.
and bladder (VB2) specimens by at least 1 logarithm. The
patients discussed today illustrate the diagnostic usefulness of
this technique.
Acute bacterial prostatitis. Acute bacterial prostatitis pro-
duces such characteristic signs and symptoms that the diagnosis
is usually obvious. Typically the patient experiences sudden
chills, fever, low-back and perineal pain, and general malaise
and prostration. Arthralgia and myalgia are common symp-
toms, as are intense irritative voiding symptoms (urgency,
frequency, nocturia, and dysuria) and varying degrees of blad-
der outlet obstruction. Rectal examination reveals a markedly
tender prostate that feels swollen, indurated, and warm. Al-
though the prostatic expressate is purulent in acute prostatitis
and usually yields confluent growth of the pathogen on culture,
massage of an acutely inflamed prostate is an unwise procedure
because of patient discomfort and the risk of bacteremia. Given
that acute bacterial prostatitis is quickly followed by acute
cystitis in most cases, the pathogen usually can be identified by
culturing the voided urine.
Hospitalization and general supportive measures such as
hydration, antipyretics, analgesics, bed rest, and stool softeners
are usually required. Since urethral instrumentation should be
avoided, urinary retention requiring bladder drainage should be
managed by percutaneous placement of a suprapubic catheter
rather than by an indwelling urethral catheter.
The diffuse, intense inflammation of acute prostatitis proba-
bly alters pharmacologic response sufficiently to allow many
drugs that normally are excluded to diffuse readily into prostatic
fluid. We still prefer to initiate antibacterial therapy with TMP-
SMX, however. We use 160 mg of TMP and 800 mg of SMX
twice daily until the results of culture and sensitivity testing are
available. If the pathogen is sensitive and the clinical response
is favorable, we continue therapy with this dose for at least 30
days in the hope of preventing chronic prostatitis. Alternative-
ly, therapy can be initiated with gentamicin or tobramycin, 3 to
5 mg/kg per day, divided into 3 intramuscular or intravenous
doses, plus ampicillin, 2 gm given intravenously every 6 hours.
A suitable oral antimicrobial agent should be substituted after 1
week and given in full dosage for at least 30 days. Although
most patients with acute bacterial prostatitis are cured by
medical therapy, some develop chronic prostatitis.
Chronic bacterial prostatitis. Despite its highly variable
clinical features, chronic bacterial prostatitis is a common cause
of relapsing urinary tract infection in men. Many patients deny
preceding bouts of acute prostatitis; some men are diagnosed
only because asymptomatic bacteriuria is found incidentally;
most patients experience variable irritative voiding symptoms
and pain perceived at various sites (suprapubic, perineal, low
back, scrotal, penile, or inner thigh areas). Some complain of
postejaculatory pain and/or experience intermittent hemosper-
mia. Chills or fever are unusual unless an acute exacerbation of
the chronic infection occurs. A boggy or tender prostate is not
diagnostic of chronic bacterial prostatitis. Recurrent epididymi-
tis often denotes an underlying prostatic infection, especially in
men over the age of 35.
The most characteristic feature of chronic bacterial prostati-
tis is relapsing bacteriuria in which the same pathogen is found
repeatedly. The organism persists in prostatic fluid despite
therapy with most antibacterial agents because most drugs
diffuse poorly from plasma into prostatic ducts and acini. Even
though the urine can be sterilized and symptoms may be
controlled during therapy, cessation of medication eventually
leads to reinfection of the urine and recurrent symptoms. As
demonstrated in the patients presented today, treatment fail-
ures seldom are associated with alterations in type or sensitivity
of the infecting organism.
Chronic calculous prostatitis. Prostatic calculi develop com-
monly in middle-aged and elderly men. About 20 years ago, Fox
reviewed pelvic x-ray films of 3510 men whose average age was
56 years; he noted prostatic stones in about 14% [26]. The true
incidence of prostatic stones obviously is much higher, as many
such calculi are not visible on x-ray films. Indeed, Fox exam-
ined a large number of autopsy and surgical specimens and
concluded that tiny prostatic stones can be found in virtually
every adult prostate. Although these stones can cause shedding
of inflammatory cells into prostatic secretions, they generally
are harmless and produce no symptoms as long as they are
confined to the gland and its ducts. However, in certain men
with prostatic stones and relapsing bacteriuria, bacterial patho-
gens within the calculi have proved to be the source of the
relapsing bacteriuria [27]. Similar to infected kidney stones,
such prostatic calculi are impregnated to the core with bacteria
that are totally protected from contact with antimicrobial
agents. As in Patient 3, successful removal of these infected
calculi by surgical means is the only chance for cure.
Little is known about the formation and significance of
prostatic calculi. However, urethroprostatic reflux of urine
might play an important role in stone formation and the
pathogenesis of bacterial prostatitis. Moreover, unrecognized
infected calculi might play a more important role than do
unfavorable pharmacokinetics in our inability to cure chronic
bacterial prostatitis by antimicrobial therapy.
Prostatic dysfunction. The profound alteration in the compo-
sition of prostatic fluid in patients with chronic bacterial prosta-
titis indicates that a severe, generalized secretory dysfunction is
present (Table 5). This secretory dysfunction almost certainly
influences the passage of antimicrobial agents into prostatic
fluid, particularly as the secretions become more alkaline than
normal. The difference in pH of plasma and prostatic fluid is
thought to be a critically important factor influencing the
nonionic diffusion of drugs from plasma across the lipid mem-
brane of prostatic epithelium. Recent studies indicate that
• Control
C Urethritis
U Prostatitis
DL
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High levels Medium-to-low levels
Rosamicin Chloramphenicol
Trimethoprim (TMP) Lincomycin
Clindamycin
Erythromycin
Oleandomycin
Low-to-negligible levels
OxytetracyclineAmpicillin
Cephalothin Penicillin G
Cephalexin Polymyxin B
Doxycycline Rifampin
Kanamycin Rifamide
Minocycline Most sulfonamides
Nitrofurantoin Tetracycline
unlike the slightly acidic or slightly alkaline pH of prostatic fluid
in normal men, prostatic secretions in men with chronic bacteri-
al prostatitis are distinctly alkaline (mean pH of 8.0 or greater)
[151. This alkaline milieu inhibits the passage of antimicrobial
agents that are bases (such as TMP) into the prostatic fluid but
enhances the passage of other drugs (such as minocycline).
The prostatic fluid of dogs, rats, and normal humans contains
a potent prostatic antibacterial factor (PAF) that is bactericidal
to most Gram-positive and Gram-negative organisms. This
factor has been identified as a compound of zinc, and it
probably is a zinc salt [291. Zinc concentrations are low and
PAF activity is depressed or absent in men with chronic
bacterial prostatitis; some researchers believe therefore that
zinc (PAF) serves as a natural defense mechanism against
ascending genitourinary infection in normal men. The important
question is whether men become infected because their prostat-
ic secretions have inadequate levels of zinc (PAF) or whether
zinc (PAF) is depressed as a consequence of the infection.
Indeed, since the prostatic fluid concentration of all cations, not
just zinc, is depressed in chronic bacterial prostatitis, the low
levels of zinc might represent an effect rather than a cause of the
infection. Additional studies are warranted to clarify the inter-
relationships of prostatic infection and secretory dysfunction of
the gland. Although some clinicians advocate the use of oral
zinc preparations for treating chronic bacterial prostatitis, it is
not known whether the level of zinc in prostatic secretions is
increased by oral administration of the substance.
Drug diffusion into prostatic fluid. Experiments performed in
dogs show that most antimicrobial agents normally useful
against Gram-negative pathogens diffuse poorly from plasma
into prostatic fluid; a notable exception is TMP [151. The
relative levels of various drugs reaching prostatic secretions are
shown in Table 6. Rosamicin, a promising new macrolide, is
still under investigation by the manufacturer and currently is
not available for clinical use. Assays of human prostatic tissue
indicate that several antimicrobial agents achieve potentially
therapeutic levels within prostatic stroma and interstitium;
however, clinical studies clearly indicate that cure of chronic
bacterial prostatitis correlates best with the antimicrobial level
in prostatic secretions, not tissue.
The general principles that govern the transport of drugs
across all human lipid membranes apply to the nonionic diffu-
sion of antimicrobial agents from plasma across prostatic epi-
thelium into prostatic fluid. To permeate the lipid membrane, a
drug must be lipid soluble and not bound to plasma proteins.
Because only the nonionized portion of a drug is lipid soluble,
the dissociation constant in plasma (pKa) of the drug also is
critically important in diffusion. Moreover, whether the drug is
an acid or base influences diffusion, especially when the pH
values of plasma and prostatic secretions differ significantly.
Diffusion experiments were performed in healthy dogs whose
prostatic secretory function was assumed to be normal. The pH
of prostatic secretions was measured in most animals and found
uniformly slightly acidic. As noted earlier, in chronic prostatitis
it is likely that reversal of the normal pH relationship between
prostatic fluid and serum by increased alkalinity of the fluid
alters the transport of certain drugs across prostatic epithelium.
Indeed, Stamey, Bushby, and Bragonje studied the diffusion of
TMP in normal dogs and observed prostatic fluid/serum ratios
of 5.9 to 7.0, as compared with saliva/serum ratios of 0.7 to 0.9
[30]. The average pH of prostatic fluid in all dogs ranged from
5,7 to 6.2, as compared with the uniformly alkaline pH of saliva
(7.8 to 8.8). Fair studied the diffusion of minocycline in dogs
and noted higher levels in saliva (alkaline pH), as compared
with prostatic fluid (acidic pH) [311.
Since increased alkalinity of the prostatic secretions is associ-
ated with chronic bacterial prostatitis, results obtained in drug
diffusion experiments in dogs whose prostatic secretions are
acidic cannot be used explicitly to predict clinical response of
antimicrobial therapy in this condition. But until precise meth-
ods are developed that will conveniently and accurately mea-
sure antimicrobial levels in human accessory gland fluids, the
results of diffusion studies characterizing prostatic fluid and
salivary levels in the dog model continue to serve a useful
purpose.
Medical treatment. Regardless of theoretical concerns about
the concentration of TMP in excessively alkaline prostatic
secretions, trimethoprim-sulfamethoxazole is the antimicrobic
drug with the best documented record of success in treating
chronic bacterial prostatitis. Among patients who received
long-term therapy (4 to 16 weeks), the cure rates have been 32%
to 71%, a rate more than twice those noted with short-term
therapy (2 weeks or less) [15]. We prefer to treat patients who
have susceptible pathogens with TMP-SMX, one double-
strength tablet (160 mg of TMP, 800 mg of SMX), twice daily for
12 weeks. Patients who are allergic to sulfonamides or trimetho-
prim, or those who have azotemia, hematologic disorders, or
Table 5. Prostatic fluid alterations in bacterial prostatitis'
Increased
1. pH
2. Ratio of LDH isoenzyme 5 to LDH isoenzyme 1 (LDH-5/LDH-l =
 2)
Decreased
1. Specific gravity
2. Prostatic antibacterial factor (PAF)
3. Cation concentrations (zinc, magnesium, calcium)
4. Citric acid concentration
5. Spermine concentration
6. Cholesterol concentration
7. Enzyme concentrations (acid phosphatase, lysozyme)
Modified from Ref. 28.
Table 6. Prostatic fluid levels of drugs attained in normal dogs
Modified from Ref. 15.
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liver ailments might not be suitable candidates for this regimen,
however.
Both erythromycin and minocycline are acclaimed as effec-
tive agents in the therapy of chronic bacterial prostatitis. The
results of animal experiments suggest that each drug occasion-
ally might attain therapeutic levels when prostatic secretions
are very alkaline. Although erythromycin is inactive against
Gram-negative organisms in acidic environments, alkaline envi-
ronments increase its efficacy [32]. Both drugs are character-
ized by a high incidence of adverse side effects and neither is
suitable for long-term use.
The assertion that oral carbenicillin is effective in curing
chronic bacterial prostatitis requires substantiation. Prelimi-
nary studies reported by Oliveri, Sachs, and Caste seem
encouraging [33]. It is unfortunate, however, that posttherapy
follow-up examinations in these studies were limited to one
month. Since relapses occur commonly in patients with chronic
bacterial prostatitis between one and 4 months after completion
of apparently successful therapy, one cannot accurately evalu-
ate the definitive results of any treatment for this disease with
follow-up examination of only one month.
Patients not cured by medical therapy usually can be man-
aged satisfactorily by continuous suppressive therapy with low-
dose medication. Preferred regimens include TMP-SMX, 1
single-strength tablet daily, or nitrofurantoin, 100 mg by mouth
once or twice daily. Suppressive therapy usually controls
symptoms and prevents bacteriuria. Because the pathogen
persists within the prostate, however, discontinuation of thera-
py eventually results in recurrent symptoms and bacteriuria.
Surgical treatment. Although total prostatovesiculectomy
offers the best hope for cure, postoperative sequelae such as
erectile impotence and possible urinary incontinence seldom
make this a desirable solution for the patient who has incurable
chronic bacterial prostatitis. Provided all foci of infected tissue
and calculi are removed, transurethral prostatectomy can be
curative, as illustrated in Patient 3. The inflammation in chronic
bacterial prostatitis occurs mainly in the peripheral portions of
the gland; therefore, complete resection is required for success-
ful results. Since many men with chronic bacterial prostatitis
might have unsuspected infected calculi, careful prospective
study of the role of transurethral prostatectomy in the manage-
ment of medically incurable chronic bacterial prostatitis is
warranted.
Questions and answers
DR. JEROME P. KASSIRER: Dr. Meares, what is the correlation
between bacterial and leukocyte counts in the prostatic expres-
sate and parenchymal infection of the prostate? How can we be
confident that a patient with a positive culture and with greater
than 10 leukocytes per high-power field actually has an infected
gland? Do apparently normal individuals sometimes have such
findings?
DR. MEARES: Although normal men can experience transient
colonization of their urethral surface by small numbers of
Gram-negative bacteria, such colonization seldom causes
symptoms and usually disappears spontaneously. Furthermore,
short-term therapy with antimicrobial agents that achieve thera-
peutic levels in the urine but not in the serum or prostatic fluid
quickly clears these bacteria from the segmented cultures
without relapse. Men who have segmented cultures indicative
of prostatic infection do not clear these bacteria spontaneously
and show persistently positive prostatic cultures despite pro-
longed therapy with appropriate antimicrobics that achieve high
urinary levels and therapeutic levels in plasma but low levels in
prostatic fluid. Localization cultures performed in normal male
volunteers have failed to show higher counts of bacteria in
prostatic specimens than in urethral specimens [16]. Indeed,
even urethral colonization with pathogenic bacteria is unusual
in normal men.
Current methods do not permit us to diagnose infection of the
prostatic parenchyma that exists without concomitant infection
of the prostatic fluid. It seems unlikely that this combination
would occur, except perhaps as a consequence of hematoge-
nous or lymphogenous spread of infection. Because pharmaco-
kinetic studies indicate that most antimicrobial agents achieve
levels in the prostatic interstitium and tissue that far exceed the
drug levels in prostatic fluid, cure of parenchymal infection
poses less difficulty than does cure of infection within the
secretory glands and ducts.
DR. ROBERT RUBIN (Chief of Nephrology, Lemuel Shattuck
Hospital, Boston, Mass.): With the recent availability of tn-
methoprim alone, would you consider changing your mode of
therapy to just trimethoprim rather than its combination with
sulfa?
DR. MEARES: The U.S. Food and Drug A dministration has
approved neither tnimethopnim-sulfamethoxa cole nor trimetho-
prim alone for specific use in the therapy of b Lcterial prostatitis.
That agency requires proof of the drugs' eff cacy that is based
on prospective, randomized studies comp tring these agents
with other antimicrobial agents in patienl s with prostatitis.
Although such studies are being carried out by various investi-
gators, conclusive results are not yet available. Whether suffi-
cient amounts of sulfamethoxazole enter prostatic fluid to
enhance the antibacterial action of trimethoprim in patients
with chronic bacterial prostatitis remains speculative. If there is
no added advantage to administering sulfamethoxazole in com-
bination with trimethoprim, then therapy with trimethoprim
alone may prove more efficacious because the content of
trimethoprim in two tablets of the combination (160 mg) is less
than the content in two tablets of trimethoprim alone (200 mg).
DR. WARREN GOORNO (Nephrolo gist, Emerson Hospital,
Concord, Mass.): In practice it seems that a large percentage of
patients with acute prostatitis respond to many drugs, but
specifically to tetracycline or ampicillin. Given your data,
would you suggest using these agents as first-line drugs? My
patients seem to experience intolerance to drugs like trimetho-
prim-sulfamethoxazole.
DR. MEARES: In cases of acute bacterial prostatitis, cure may
be achieved by many of the antimicrobial agents that fail to
eradicate the infecting organisms in chronic prostatitis. Theo-
retically, the intense inflammatory reaction accompanying
acute infection alters the lipid membrane barrier that normally
prevents diffusion and accumulation of certain drugs in prostat-
ic fluid. Increased diffusion of antibiotics into prostatic fluid
actually has been shown in dogs in which bacterial prostatitis
has been induced experimentally [34].
Despite the probable increase in the diffusion of drugs into
prostatic fluid that is associated with acute inflammation, I
prefer using trimethoprim alone or in combination with sulfa-
methoxazole in the treatment of acute bacterial prostatitis.
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Trimethoprim, which definitely accumulates in prostatic fluid,
is bactericidal to most pathogens at low concentrations. In my
view, an important goal of therapy in acute prostatitis is total
eradication of the infecting organisms so that chronic bacterial
prostatitis does not evolve. Even long-term therapy with tn-
methoprim-sulfamethoxazole has been tolerated exceedingly
well by my patients. I believe this has been the experience of
most investigators who have used this drug combination to treat
a wide variety of infectious diseases.
DR. JOHN T. HARRINGTON: You mentioned that anaerobic
bacteria are rarely important pathogens in prostatitis. Can this
be explained by what we know about prostatic tissue metabo-
lism or the relative oxygenation of this tissue as compared with
other normal tissues in the body?
DR. MEARES: Although anaerobic bacteria commonly inhabit
the urethra in men and the vagina in women, urinary tract
infection due to obligate anaerobes is uncommon in both sexes.
Obligate anaerobic bacteria can cause prostatitis and even
prostatic abscesses; however, several studies indicate that
prostatitis due to anaerobic bacteria is uncommon [1, 2, 6]. The
reason why anaerobic bacteria are infrequent pathogens in
prostatitis and urinary tract infections is unclear. I know of no
studies that have investigated the possible role of oxygenation
of prostatic tissue or secretions in the pathogenesis of infection.
DR. HARRINGTON: Would you comment further on urody-
namic studies performed in men with prostatodynia?
DR. MEARES: Video-urodynamic studies performed in normal
men show synergistic activity between the bladder musculature
and the external sphincter mechanism during voiding. At the
onset of voiding, the bladder muscle contracts, the bladder neck
opens, and the external sphincter relaxes, permitting unob-
structed flow. Bladder-sphincter dyssynergia, characterized by
failure of relaxation or even increased activity of the external
sphincter mechanism as the bladder muscle contracts during
voiding, results in an obstructed voiding pattern.
Some authorities believe that bladder-sphincter dyssynergia
occurs only in patients who have diseases of the central nervous
system. Recently several laboratories, including our own, have
observed that many men with prostatodynia have voiding
abnormalities that simulate the urodynamic findings of bladder-
sphincter dyssynergia [10]. These men have no signs or symp-
toms of central nervous system disease and their neurologic
examinations are normal. A possible explanation is that the
voiding abnormality occurring in prostatodynia is an acquired
phenomenon that is primarily psychosomatic. We postulate that
these men experience an initial bout of urethritis or prostatitis
that causes pain and discomfort during voiding. Even though
the original cause of the painful voiding is cured by therapy, the
subconscious mind remembers the discomfort and initiates
spasm of the external sphincter mechanism at the time of
bladder contraction in an effort to prevent urination. If this
theory is correct, cure of this voiding abnormality might require
techniques of biofeedback to help the patient "unlearn" this
reflex and restore normal voiding.
DR. STEPHEN ZELMAN (Renal Fellow, NEMCH): When a
patient has chronic bacterial prostatitis and low levels of zinc
and prostatic antibacterial factor in his prostatic secretions, is
there a return to normal of these and other characteristics of
prostatic fluid following successful treatment?
DR. MEARES: This important question needs careful study.
We are still uncertain whether men develop bacterial prostatitis
because they have preexisting secretory dysfunction of the
gland, or whether they acquire secretory dysfunction as a result
of bacterial prostatitis. Data obtained on a few men apparently
cured of chronic bacterial prostatitis by antimicrobial therapy
suggest that prostatic fluid tends to become less alkaline during
treatment than during the infection; however, other features of
the secretions have not been studied following successful
treatment.
Secretory dysfunction of the prostate might play a role in
male fertility. Some researchers claim that asymptomatic infec-
tions of the prostate and seminal vesicles cause infertility in
certain couples, and that fertility sometimes can be restored by
elimination of the infection [15, 28]. In-vitro studies suggest that
massive inocula of bacteria are necessary to impair sperm
viability directly; however, seminal vesicular fluid exerts a
deleterious effect on sperm in ejaculates that are devoid of
normal prostatic fluid [15]. One can postulate from these
observations that the secretory dysfunction in chronic prostati-
tis can impair fertility. Careful studies are needed to define
more clearly the role of chronic bacterial prostatitis in impaired
fertility.
DR. ANDREW LEVEY (Renal Fellow, NEMCH): What pro-
portion of men with recurrent urinary tract infections have
underlying prostatic infections as the basis of their problem?
DR. MEARES: I am not aware of any epidemiologic studies
that have been designed to define conclusively the incidence of
acute and chronic urinary tract infections on the basis of an
underlying source of prostatic infection. No doubt men do
acquire urinary tract infections without preexisting or concomi-
tant prostatic infection. Unless these men have infected urinary
stones or structural genitourinary tract abnormalities, their
urinary tract infections usually respond favorably to appropri-
ate antimicrobic therapy without relapse. When a man has no
genitourinary tract abnormalities and no urolithiasis but experi-
ences recurrent urinary tract infection with the same pathogen,
our data both at Stanford and here in Boston indicate that the
prostate, not the kidney, is the usual site of bacterial persis-
tence [13, 15, 16, 25]. The three patients discussed today
illustrate this point.
DR. HARRINGTON: Does your experience reflect specific
referral patterns or is it indicative of unselected patients as
well?
DR. MEARES: Much of our early work in prostatitis was done
at the Veterans Administration Hospital in Palo Alto, Califor-
nia. Patient selection was minimized because the Section of
Urology generally served as primary care physicians for pa-
tients presenting with urinary tract infections. Much of my
practice at Stanford and here in Boston consists of unselected
patients, although I confess that in recent years there has been a
trend toward more complicated referrals. Most of the men
whom I see with a prostatitis syndrome do not have bacterial
prostatitis but suffer from nonbacterial prostatitis or prostato-
dynia. Regardless of concerns about patient selection, most
men experiencing recurrent urinary tract infection due to a
consistent pathogen have a persistent source of infection within
the prostate. The pathogen persists within the acini and ducts
because most antimicrobial agents fail to attain therapeutic
levels in prostatic fluid. These pathogens rarely change in type
or susceptibility to antibacterial agents.
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stones and infection?
DR. MEARES: Most men who have prostatic stones visible on
x-ray films do not have recurrent urinary tract infection or
infected calculi. On the other hand, when a man has chronic
bacterial prostatitis and prostatic calculi, the stones usually are
impregnated with the infective pathogen. In the urinary tract,
infection with organisms that split urea, notably Proteus mirabi-
us, produce marked alkalinization and the rapid formation of
struvite calculi. These bacteria not only participate in stone
formation but become part of the stone from surface to core.
The role of infection in the formation of prostatic calculi is not
clear. Most of the men whom we have treated for chronic
calculous prostatitis have had infection due to various strains of
E. coli, and not to organisms that split urea. Most likely the
infection is not primarily responsible for the formation of
prostatic calculi, but rather the stones form first and become
secondarily infected with the prostatic pathogen.
Reprint requests to Dr. Edwin M. Meares, Jr., Department of
Urology, New England Medical Center Hospital, 171 Harrison Avenue,
Boston, Massachusetts 02111, USA
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DR. LEVEY: It is general practice to obtain an intravenous
pyelogram to evaluate the upper urinary tract in men who have
acute urinary tract infection. Should we also obtain YB 1, VB2,
EPS, and VB3 cultures in these patients?
DR. MEARES: I believe that acute urinary tract infection
should be treated with antimicrobial drugs according to suscep-
tibility testing and clinical response to therapy. If the signs and
symptoms suggest accompanying acute bacterial prostatitis, the
patient should, in my view, receive appropriate therapy for at
least 30 days to prevent chronic prostatitis. During careful
follow-up examinations, if the patient shows relapse of bacteri-
uria with the same pathogen, localization cultures should be
performed to investigate the possibility of a prostatic source. I
wish to emphasize, however, that proper interpretation of the
comparative cultures requires careful attention to detail during
collection of the segmented specimens and in culture method-
ology.
DR. ZELMAN: Has an association been found between stone
formation in the kidneys and in the prostate? Do patients with
prostatic calculi ever have metabolic disorders as the basis for
their stone formation?
DR. MEARES: Several years ago, Fox suggested an interrela-
tionship between nephrolithiasis and prostatic calculi because
the incidence of prostatic calculi seemed higher in men who also
had kidney stones than in men who did not [261. To my
knowledge, however, conclusive studies regarding the possible
relationship of prostatic calculi to nephrolithiasis or to metabol-
ic disorders have never been performed. Most prostatic calculi
are composed of tricalcium phosphate and have a crystalline
structure that is distinctly different from stones formed within
the kidney. Some investigators refer to these as "endogenous"
prostatic stones. Surprisingly, many prostatic calculi comprise
constituents commonly found in urine but foreign to prostatic
secretions. These calculi are referred to as "exogenous" pros-
tatic stones. One might speculate that most endogenous stones
form as a consequence of local factors within the prostate,
whereas most exogenous stones form mainly as a result of
changes in urine that are associated with metabolic alterations.
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